BOSTON SCIENTIFIC CORPORATION Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased
BOSTON SCIENTIFIC CORPORATION (BSX) had Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased of 21.00 million shares as of 2012-12-31, per its 8-K filed 2013-05-29.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased · last filed 2013-05-29
- 2012-12-31: Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 21.00M shares.
- 2011-12-31: Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 37.00M shares.
| Period end | Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased |
|---|---|
| 2012-12-31 | 21.00M shares 8-K · filed 2013-05-29 |
| 2011-12-31 | 37.00M shares 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |